ABEONA THERAPEUTICS INC. (ABEO) › Operating Cash FlowABEONA THERAPEUTICS INC. (ABEO) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2010: -$6.86M2011: -$7.61M2012: -$3.96M2013: $1.0K2016: -$13.01M2017: -$22.66M2018: -$39.11M2019: -$62.82M2020: -$35.02M2021: -$65.67M2022: -$43.48M2023: -$37.01M2024: -$56.02M2025: -$76.33M-$76.33M2010Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$76.33M-36.3%2024-$56.02M-51.4%2023-$37.01M+14.9%2022-$43.48M+33.8%2021-$65.67M-87.5%2020-$35.02M+44.3%2019-$62.82M-60.6%2018-$39.11M-72.6%2017-$22.66M-74.1%2016-$13.01M—2013$1.0K+100.0%2012-$3.96M+48.0%2011-$7.61M-10.9%2010-$6.86M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share